1,721,148 research outputs found
Advanced nonlinear controllers for the chemotherapy of brain tumor
Full text linkBrain tumors represent a significant challenge in the medical field due to their
complex nature and the critical environment in which they develop. These tumors
result from the abnormal proliferation of cells within the brain, leading to the
formation of masses that can be either benign or malignant. The treatment approach
for brain tumors is highly dependent on the type, the location, and the severity of
the tumor. Malignant brain tumors, in particular, present a substantial challenge
due to their aggressive growth patterns and their proximity to essential brain tissues.
Because of the sensitive nature of brain tissue and the intricate location of these
tumors, surgical intervention, which is a common treatment for other types of
tumors, is often not recommended for malignant brain tumors. The reason for
this caution is that malignant tumors are frequently intertwined with critical and
sensitive areas of the brain, making surgical removal risky and potentially leading to
severe neurological damage or loss of critical brain functions.
As a result, alternative treatment strategies, such as chemotherapy, become
crucial for managing malignant brain tumors. Chemotherapy involves the adminis
tration of drugs designed to target and kill rapidly dividing tumor cells; however,
the effectiveness of chemotherapy is heavily reliant on precise dosing and timing.
The goal is to maximize the elimination of tumor cells, while minimizing damage
to healthy brain cells and preserving the patient’s immune function. Striking this
balance is critical because an overdose of chemotherapy drugs can lead to toxicity
and damage to healthy tissues, while an underdose may not be effective in controlling
tumor growth. Therefore, the precise control of chemotherapy dosing is essential to
achieve the best possible treatment outcomes.
This research focuses on developing advanced nonlinear controllers to optimize
chemotherapy dosing. These controllers, including Adaptive Terminal Sliding Mode
Control (AT-SMC), Adaptive Super-Twisting Sliding Mode Control (AS-SMC), Ter
minal Synergetic Control (TSC), Fuzzy Logic Control (FLC), and Barrier Function
Based Sliding Mode Control (BF-SMC), are designed to dynamically adjust the
chemotherapy dosage in response to the tumor’s progression, ensuring that tumor
cells are effectively targeted while healthy cells are preserved.
The controllers are rigorously tested using MATLAB simulations under various
conditions to evaluate their effectiveness in maintaining the balance between eliminat
ing tumor cells and preserving healthy tissue. The stability and convergence of these
systems are verified using Lyapunov theory, which confirmed that the controllers are
capable of achieving the desired outcomes. Among the tested strategies, AT-SMC,
AS-SMC, and BF-SMC showed the most promising results, demonstrating minimal
steady-state error, fast convergence, and efficient drug usage. These findings suggest
that advanced nonlinear control strategies hold significant potential for enhancing
the effectiveness of chemotherapy in treating brain tumors, offering a more targeted
and safe approach to managing this challenging condition
)A new transpalatal distraction device: report of three cases with surgical and occlusal evaluations A. Cortese, M. de Cristofaro, F. Papa, G. Savastano Riv. Ital. Chir. Maxillo-Facciale 2003;14:23-9
No full textMEDEA multimedia CD. Manual for Earthquake Damage Evaluation and safety Assessment for masonry and reinforced concrete buildings
No full text)A new transpalatal distraction device: report of three cases with surgical and occlusal evaluations A. Cortese, M. de Cristofaro, F. Papa, G. Savastano Riv. Ital. Chir. Maxillo-Facciale 2003;14:23-9
No full text
CD Multimediale MEDEA. Manuale di Esercitazione sul Danno Ed Agibilità per edifici ordinari in muratura
No full text
- …
